Global Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Region: Trend Forecast and Growth Opportunity

Global radiofrequency-based devices market will reach $12,158.3 million by 2031, growing by 12.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain.
Highlighted with 82 tables and 78 figures, this 163-page report "Global Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global radiofrequency-based devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global radiofrequency-based devices market in every aspect of the classification from perspectives of Product, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Generators
• Electrodes
• Applicators
• Probes
• Cannulas
• Needles
• Other Products

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pain Management
• Aesthetics
• Oncology
• Cardiology
• Gynecology
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ALMA Lasers (Sisram Medical Ltd.)
AngioDynamics, Inc.
AtriCure, Inc.
Avanos Medical, Inc.
Becton Dickinson and Company
Boston Scientific Corporation
Bramsys Industria e Comercio Ltda
BVM Medical Limited
Conmed Corporation
Cutera, Inc.
Cynosure
Diros Technology Inc.
Johnson & Johnson
Medtronic Plc
Merit Medical Systems, Inc.
Smith & Nephew plc
Stryker Corporation
Venus Concept, Inc.
YA-MAN Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)